IFF Pharma Solutions, a leading global innovator in pharmaceutical polymers and excipients and part of IFF is set to make a significant impact at Excipient World 2025. This premier event, dedicated exclusively to excipient innovation, will take place at the Gaylord National Resort and Convention Center in National Harbor, Maryland, USA, from May 13–14, 2025. Visitors can find IFF Pharma Solutions at Booth 205, where they will unveil a dynamic portfolio designed to meet the pharmaceutical industry’s evolving needs for sustainability, performance, and safety.
In line with their forward-looking vision, IFF Pharma Solutions plans to highlight a series of cutting-edge advancements that reflect their deep commitment to a healthier, more sustainable future. The company’s display will focus on three major areas: sustainable excipient innovations, controlled-release formulation technologies, and nitrosamine risk mitigation solutions.
“We see sustainability not merely as an obligation but as a powerful driver of innovation,” stated Dr. Anne Adden, Global Strategic Marketing Director for Sustainability and Dietary Supplements at IFF Pharma Solutions. “Our mission is to create excipient solutions that address the demands of today’s pharmaceutical industry while safeguarding the resources and health of future generations. Our multidisciplinary teams are redefining leadership in sustainable healthcare through innovation, scientific rigor, and collaboration.”
Championing Sustainability Through Innovation
With over 75 years of experience in developing advanced materials for the pharmaceutical sector, IFF Pharma Solutions has consistently set benchmarks for excellence, reliability, and innovation. At Excipient World 2025, the company will showcase how sustainability is intricately woven into every aspect of their operations—from raw material sourcing to manufacturing practices and end-product performance.
Key sustainable innovations that will be featured include:
- Low Nitrite METHOCEL™ Hydroxypropyl Methylcellulose (HPMC): Specially engineered to address the growing concern about nitrosamine contamination in pharmaceutical products, this next-generation material offers enhanced safety profiles without compromising functionality.
- Avicel® PH LN (Low Nitrite): A high-purity, microcrystalline cellulose product designed for oral solid dosage forms, Avicel® PH LN supports manufacturers seeking to lower nitrosamine risks while maintaining robust tablet performance.
Both solutions are critical in helping pharmaceutical companies meet stricter regulatory standards on nitrosamine content and demonstrate IFF’s proactive approach to safety, sustainability, and compliance.
Dr. Adden emphasized, “Our sustainable excipient solutions are not incremental improvements—they represent transformative changes. We are looking at the entire lifecycle of our products, ensuring that from inception to delivery, we are making choices that prioritize health, safety, and environmental responsibility.”
Portfolio Highlights: A Legacy of Innovation
IFF Pharma Solutions will present a portfolio that reflects its long-standing tradition of innovation:
METHOCEL™ — Pioneering Then, Innovating Now
METHOCEL™, a trusted name in the industry for decades, remains a cornerstone in pharmaceutical formulations, known for its reliable performance in controlled-release applications. Now reimagined with a focus on reducing impurities and enhancing environmental stewardship, METHOCEL™ continues to empower formulators to meet the demands of today’s health-conscious consumers and stringent regulatory environments.
ETHOCEL™ — Proven Time After Time
The ETHOCEL™ brand represents consistency, performance, and versatility. This family of ethylcellulose polymers enables sustained drug release and robust protection against moisture, making it a preferred choice for diverse applications, including taste-masking, moisture barriers, and film coating.
POLYOX™ — Versatile Across Complex and Unique Applications
POLYOX™ Water-Soluble Resins are recognized for their exceptional versatility in creating innovative dosage forms. With applications ranging from controlled-release matrices to mucoadhesive delivery systems, POLYOX™ demonstrates IFF Pharma Solutions’ ability to meet complex formulation challenges across a wide range of therapeutic categories.
Through these trusted brands, IFF underscores its commitment to delivering performance without compromise—an essential criterion in today’s complex pharmaceutical landscape.
Advancing Knowledge: “Sustainable by Design” Presentation
As part of their commitment to industry leadership and knowledge sharing, Dr. Anne Adden will present an insightful talk titled “Sustainable by Design: The Future of Excipients” on May 13, from 2:00 to 2:45 p.m. ET at the Riverview Ballroom, Stage 2.
This presentation will explore how sustainability principles are applied throughout the excipient development process—from initial material selection and manufacturing efficiencies to packaging innovations and lifecycle assessments. Dr. Adden will also discuss the broader impact of sustainable practices on pharmaceutical supply chains and regulatory compliance.
“True sustainability is systemic,” Dr. Adden explained. “It is not enough to focus on the end product; we must consider how every step in the excipient lifecycle—from raw material sourcing to waste management—affects our health and our planet. Through innovation, partnerships, and scientific integrity, we can create excipients that not only perform exceptionally but also contribute meaningfully to global sustainability goals.”
Her presentation promises to offer valuable insights for pharmaceutical scientists, formulators, regulatory professionals, and sustainability leaders seeking to navigate the increasingly complex expectations around environmental and social governance (ESG) in healthcare.
Meeting Industry Challenges Head-On
The pharmaceutical industry is under growing pressure to address a host of challenges, including:
- Increasing regulatory scrutiny on impurities like nitrosamines
- Consumer demand for greener, cleaner formulations
- Supply chain disruptions emphasizing the need for robust, sustainable sourcing
- Rising competition in global markets requiring more efficient, cost-effective solutions
IFF Pharma Solutions is positioning itself at the forefront of this dynamic environment. Their investments in R&D, commitment to sustainability, and global reach enable them to support customers at every stage of drug development and commercialization.
With operations in over 40 countries and a team of world-class scientists, technologists, and customer care specialists, IFF Pharma Solutions delivers end-to-end value—from technical formulation support to regulatory guidance and market insights.
IFF Pharma Solutions
As a business division of International Flavors & Fragrances Inc. (IFF), IFF Pharma Solutions plays a pivotal role in the company’s mission to innovate for a better world. The division offers a broad range of excipients and polymer solutions that enable optimized delivery, enhanced stability, and better therapeutic outcomes for patients worldwide.
IFF’s legacy of innovation is backed by strong scientific research, market-driven solutions, and a deep commitment to ethics, safety, and sustainability. Their Pharma Solutions team embodies these principles, translating them into practical, impactful solutions that meet the highest standards of the pharmaceutical industry.
Join IFF Pharma Solutions at Excipient World 2025
Excipient World 2025 provides the ideal platform for IFF Pharma Solutions to engage with industry leaders, share new developments, and collaborate with partners seeking better excipient solutions. Attendees are invited to visit Booth 205 to meet with IFF’s technical experts, view demonstrations, and discuss how the company’s latest innovations can help them achieve their formulation goals sustainably and effectively.
In an industry facing rapid transformation, IFF Pharma Solutions offers something uniquely vital: a combination of trusted expertise, innovative spirit, and an unwavering commitment to a healthier planet and population.
